Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01101854 · ClinicalTrials.gov registry record
Gene Expression Profiles in Healing and Non-Healing Wounds
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 74
- Enrollment target
NCT01101854: Clinical Trial study, sponsored by Indiana University.
NCT01101854 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01101854 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 74 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a database containing information about genes/proteins/fats as well as wound infections in both healing and non-healing wounds. Many wounds that do not heal are infected. This study will help us determine if there is a relationship between the types of infections and how well a wound heals. Identification of genes/proteins/lipids (fats) that help predict wound healing under specific wound healing conditions will enable health care practitioners to select more appropriate treatments, monitor the responses to those treatments, and figure out what standard treatments should be.
Primary Outcome
A database of gene/protein/lipid expression and wound infection in healing and non-healing wounds.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2020-07-30 |
| Est. Completion | 2021-10-23 |
Why NCT01101854 stopped before completion
NCT01101854 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01101854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01101854 about?
NCT01101854 is a clinical study titled "Gene Expression Profiles in Healing and Non-Healing Wounds". The purpose of this study is to develop a database containing information about genes/proteins/fats as well as wound infections in both healing and non-healing wounds. Many wounds that do not heal are infected. This study will help us determine if there is a relationship between the types of infecti...
What is the current status of trial NCT01101854?
This trial is currently terminated. The enrollment target is 74 participants. The study started on 2020-07-30. Estimated completion is 2021-10-23.
Who is sponsoring clinical trial NCT01101854?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI